10-Q: XWELL Inc. Reports First Quarter 2024 Results, Revenue Up 24% Driven by XpresTest and Naples Wax

XWELL Inc. saw a 24% increase in revenue in the first quarter of 2024, primarily driven by growth in the XpresTest segment and the addition of Naples Wax Center, despite an overall operating loss.

Summary

• XWELL Inc. reported a net loss of $2.358 million for the first quarter of 2024, compared to a net loss of $5.829 million for the same period in 2023.
• Total revenue for the quarter was $8.726 million, a 24% increase from $7.063 million in the first quarter of 2023.
• The increase in revenue was primarily due to growth in the XpresTest segment, driven by an expanded CDC contract, and the addition of the Naples Wax Center.
• Operating loss for the quarter was $2.379 million, an improvement from the $6.288 million loss in the first quarter of 2023.
• The company's cash and cash equivalents totaled $4.317 million, with an additional $14.784 million in marketable securities as of March 31, 2024.
• The company's working capital surplus was $15.269 million as of March 31, 2024, compared to $17.236 million as of December 31, 2023.
• XWELL closed the Treat location in Salt Lake City International Airport in April 2024.

Sentiment

Score: 6

Explanation: The document shows positive revenue growth and improved operating loss, but the company is still operating at a loss and has material weaknesses in internal controls. The sentiment is cautiously optimistic.

Positives

• Revenue increased by 24% year-over-year, indicating growth in the business.
• The XpresTest segment's expanded CDC contract is a significant revenue driver.
• The acquisition of Naples Wax Center diversifies the company's revenue streams.
• Operating loss improved significantly, suggesting better cost management.
• Depreciation and amortization expenses decreased due to store closures, reducing costs.
• General and administrative expenses were reduced by 47%, showing effective cost optimization.
• The company has a working capital surplus of $15.269 million, indicating a healthy financial position.

Negatives

• The company reported a net loss of $2.358 million for the quarter.
• The company recorded an impairment of long-lived assets of $652 thousand.
• Interest income decreased due to less cash in interest-bearing accounts.
• The company closed the Treat location in Salt Lake City International Airport in April 2024.

Risks

• The company's ability to achieve profitability is still uncertain.
• The company is subject to legal proceedings, which could have a material adverse effect on its business.
• The company's internal controls over financial reporting were deemed not effective as of March 31, 2024.
• The company's future success depends on its ability to manage its costs and expand its business.

Future Outlook

The company is pursuing strategic partnerships to strengthen long-term profitability and plans to expand internationally and outside of airports. The company believes it has sufficient liquidity to fund operations for the next twelve months.

Management Comments

• Management believes there is opportunity to leverage a segment of products and services across the company's platform of brands.
• Management is expanding its retail strategy, adding more products for sale and aligning those products more efficiently to service offerings.
• Management plans to build capability for delivering health and wellness services outside of the airport.
• Management believes operating outside of the airport complements the offering and represents the fastest way to scale the XWELL family of brands.
• Management is looking to further expand internationally, taking advantage of the current market to grow.
• Management believes a strategy for international expansion further advances the ability to expand other brands including bio surveillance outside of the US.

Industry Context

The company is transitioning to a pure-play wellness services company, focusing on both airport and off-airport marketplaces. This aligns with the growing trend of health and wellness services and the increasing demand for travel-related wellness options. The company is also leveraging its existing infrastructure to expand into new markets and services.

Comparison to Industry Standards

• XWELL's revenue growth of 24% is a positive sign, but it is important to compare this to other companies in the travel and wellness sectors.
• Companies like Massage Envy and other airport spa operators could be used as benchmarks for XpresSpa's performance.
• The expansion of the CDC contract for XpresTest is a unique opportunity, but its long-term sustainability should be compared to other public health initiatives.
• The acquisition of Naples Wax Center is a move into a different market segment, and its performance should be compared to other waxing and skincare businesses.
• The company's operating loss, while improved, still needs to be compared to industry averages to assess its financial health.
• The company's cash position and working capital should be compared to similar companies to assess its liquidity and financial stability.

Legal Proceedings

• The company is involved in a lawsuit filed by OTG Management at Philadelphia International Airport, claiming that XWELL improperly backed out of its sublease for space at Terminal B.
• The company is involved in various other claims and legal actions that arise in the ordinary course of business.

Stakeholder Impact

• Shareholders may be encouraged by the revenue growth and improved operating loss, but concerned about the net loss and material weaknesses in internal controls.
• Employees may be affected by the company's cost optimization efforts, including headcount reductions.
• Customers may benefit from the company's expanded services and product offerings.
• Suppliers may be affected by the company's strategic partnerships and expansion plans.
• Creditors may be concerned about the company's net loss and legal proceedings.

Next Steps

• The company will continue to pursue strategic partnerships to strengthen long-term profitability.
• The company will continue to expand internationally.
• The company will continue to build its capability for delivering health and wellness services outside of the airport.
• The company will continue to monitor and improve its internal controls over financial reporting.

Key Dates

Keywords

XWELL, XpresSpa, XpresTest, Naples Wax Center, Treat, Wellness, Airport Retail, Bio-surveillance, CDC, Revenue, Financial Results, Operating Loss, Stock Split